Send feedback

PPM1D p.Ser44Trp

c.131C>G · rs373862041 · VCV1049549

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 5 submitters
AlphaMissense
likely benign
0.1438 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0483%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
intellectual developmental disorder with gastrointestinal difficulties and high pain threshold

Computational evidence

Protein change
AlphaMissense0.1438likely benign
REVEL0.13moderately benign-leaning
SaProtLLR -9.38tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 1.6GERP 1.3, phastCons 1
Regional constrainto/e 0.88unconstrained · MANE · 307 bp · p 0.13 · regional, not allelic
Overall
CADD22.9PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0483% European (non-Finnish) · 555/1,149,112 alleles
Filtering AF 0.0449% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0436%
Overall 0.0399% 620/1,553,936 alleles · ultra-rare exomes 567/1,401,658 · genomes 53/152,278 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.0676% 1,479
European (non-Finnish)grpmax 0.0483% 2,070
Remaining individualsnot grpmax-eligible 0.0316% 3,169
Ashkenazi Jewishnot grpmax-eligible 0.00699% 14,313
African / African-American 0.00545% 18,339

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PPM1D
Protein
p.Ser44Trp
Coding
c.131C>G
MANE Select
NM_003620
dbSNP
rs373862041
Type
single nucleotide variant
Location
chr17:60600545 (GRCh38)
Gene constraint
LOEUF 1.183 · pLI <0.01 · ClinGen HI 0/3 (gnomAD)
Structure
AlphaFold pLDDT 68.15 · 1 PDB
Residue 44
the ppm-type phosphatase domain; the 'interaction with chek1' region; the 'disordered' region
Full PPM1D gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ppm1d-p-ser44trp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown